Marlene Vincent, MBA
Biography
Marlene Vincent is Director of Patient Advocacy at Intercept Pharmaceuticals, where she leads global engagement strategies for the liver‑disease community—particularly PBC and rare liver diseases. Drawing on more than a decade in biotech and pharma, she has built cross‑stakeholder alliances that elevate patient voices in R&D, policy, and clinical‑trial design. Prior to Intercept, Marlene drove rare‑disease advocacy initiatives at Moderna and bluebird bio, spearheading newborn‑screening policy wins and disease‑awareness campaigns on both sides of the Atlantic. Fluent in English and Spanish, she is completing an International Master in Pharma & Public Health Management at Rome Business School. Her passion is embedding "patient engagement as a HABIT" so that meaningful, equitable outcomes become routine in liver health.